Mon, April 29, 2024
Fri, April 26, 2024
Thu, April 25, 2024

David Nierengarten Reiterated (BPMC) at Buy and Held Target at $110 on, Apr 26th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-110-on-apr-26th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Nierengarten of Wedbush, Reiterated "Blueprint Medicines Corporation" (BPMC) at Buy and Held Target at $110 on, Apr 26th, 2024.

David has made no other calls on BPMC in the last 4 months.



There are 3 other peers that have a rating on BPMC. Out of the 3 peers that are also analyzing BPMC, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $70 on, Tuesday, February 13th, 2024


These are the ratings of the 2 analyists that currently disagree with David


  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $114 on, Wednesday, April 10th, 2024
  • David Lebowitz of "Citigroup" Maintained at Strong Sell with Increased Target to $65 on, Friday, February 16th, 2024

Publication Contributing Sources